Obagi ELASTIderm® Eye Cream – 15 g
Description
Description
A lightweight eye cream formulated with Bi‑Mineral Contour Complex™ that is clinically proven to help reduce the appearance of eye area fine lines and wrinkles. For a firmer, more resilient look
Results Timeline
| When | Visible Change |
|---|---|
| 2 weeks | Noticeably firmer, smoother eye skin 97% saw less crepiness |
| 8 weeks | Fine lines softening, improved elasticity and reduced puffiness |
Bounce-back eyes—restore firmness and smoothness to the delicate eye area with Obagi’s signature Bi‑Mineral Complex™.
Featuring copper, zinc, and malonic acid, this clinically proven eye treatment supports elastin production to visibly firm skin. Lightweight and non-comedogenic, it hydrates with natural extracts—licorice, algae, blueberry—and vitamin E, while gentle exfoliation refreshes texture. Ideal for all skin types, especially those seeking age-defying eye renewal in just two weeks.
Key Ingredients & Benefits
- Bi‑Mineral Contour Complex™ (Zinc + Copper + Malonic Acid):
- Boosts elastin development—“create, convert, organise”—for eye area firmness
- Malonic Acid: Gently exfoliates to improve texture and brightness
- Vitamin E (Tocopheryl Acetate): Antioxidant protection and barrier support
- Natural Extracts (Licorice, Algae, Blueberry): Soothe, brighten, and guard against further oxidative damage
Full INCI List
Water (Aqua), Ethylhexyl Palmitate, C13‑15 Alkane, Glycerin, Cyclopentasiloxane, Glyceryl Stearate, C12‑15 Alkyl Benzoate, PEG‑100 Stearate, Dipropylene Glycol Dibenzoate, Propylene Glycol, Dimethicone, Stearyl Alcohol, PPG‑15 Stearyl Ether Benzoate, Polyacrylamide, Cetyl Alcohol, Cetyl Dimethicone, C13‑14 Isoparaffin, Xanthan Gum, Magnesium Aluminum Silicate, Laureth‑7, Tocopheryl Acetate, Glycyrrhiza Glabra (Licorice) Root Extract, Algae Extract, Vaccinium Angustifolium (Blueberry) Fruit Extract, Phenoxyethanol,… Malonic Acid, Malachite, Zinc Carbonate, Silica, Talc, Alumina, Titanium Dioxide, Mica, Iron Oxides.










0 Reviews
There are no reviews yet.